Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
Celularity Inc CELU
$1.38
▲ +4.55%
(+$0.06)
⬆️ Above Yest. High
🎈 Low Float
Open
$1.33
Prev Close
$1.32
Day Range
$1.32 – $1.41
52W Range
$0.56 – $2.55
Market Cap
$38.21M
Beta
0.87
EPS (TTM)
$-3.59
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-05-23 |
| Shares Out. | 28,950,000 |
| Website | celularity.com/ ↗ |
| Phone | 18009279800 |
| Employees | 115 |
| Revenue | $4.1M |
| Gross Profit | -$3.3M |
| Net Income | -$24.4M |
| Free Cash Flow | -$13.3M |
| Total Assets | $107.3M |
| Total Liabilities | $145.4M |
| Equity | -$38.1M |
About Celularity Inc
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Celularity Inc is a publicly traded company under the ticker symbol CELU on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2026-09-01)
📰 Latest News for CELU
Celularity Announces Initial Closing Generating Over $10M In Gross Cash Proceeds From Private Placement Of Senior Secured Convertible Notes And Warrants
Stock Market: Will S&P 500 Open Up or Down Today?
Celularity Says It Regained Compliance With Nasdaq Minimum Bid Price And Market Value Of Listed Securities Rules; Delinquent Periodic Filing Deficiency Remains Outstanding